Compare McKesson Corporation (MCK) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Newegg Commerce Inc — how do they compare? McKesson Corporation trades at $828.8 (market cap $97.35B), while Newegg Commerce Inc trades at $13.44 (market cap $270.98M). The key difference: McKesson Corporation is far larger — about 359.3× Newegg Commerce Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Newegg Commerce Inc pays none. Which is the better fit depends on your goals.
| MCK | NEGG | |
|---|---|---|
Market Cap | $97.35B | $270.98M |
Sector | Health | Consumer Cyclical |
52-Week High | $995.69 | $128.09 |
52-Week Low | $659.01 | $12.92 |
Enterprise Value | $101.98B | $269.78M |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
NEGG trades at $13.12, up 1.0% today, with a bearish technical outlook despite oversold RSI readings. The company shows improving fundamentals, with Q1 2026 EPS beating expectations and revenue stabilizing near $1.4B, though net margins remain thin at 0.39%. Recent news highlights product launches and AI shopping enhancements, signaling innovation efforts. Cash flow trends are volatile, with 2025 net cash flow positive at $8.91M but 2026 projecting a significant outflow.
The stock presents a mixed outlook: low P/S ratio of 0.19 suggests undervaluation relative to sales, but high P/E of 49.72 and consistent net losses pose risks. Analyst sentiment is bullish with a 100% buy rating, yet technical weakness and competitive e-commerce pressures require caution. Near-term catalysts include execution on profitability and AI initiatives, but investor patience is needed for sustained turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
